Astorg and International Chemical Investors Group (ICIG) have signed an agreement whereby Astorg will acquire CordenPharma, a contract development and manufacturing organization (CDMO) with differentiated capabilities in active pharmaceutical ingredients (APIs), excipients and drug products, from ICIG. As part of the transaction, the founders will take the opportunity to reinvest as partners with Astorg. The company has experienced strong organic growth thanks to its position in complex and fast...